Voices Against Brain Cancer Reacts to New Findings on the Development of Brain Tumors
New York, NY (PRWEB) December 07, 2012
On December 7, Voices Against Brain Cancer (VABC) responds to new findings in cancer research following an article published by HealthCanal.com.
According to the article, “[r]esearchers at The University of Texas MD Anderson Cancer Center have tracked down a cancer-promoting protein’s pathway into the cell nucleus and discovered how, once there, it fires up a glucose metabolism pathway on which brain tumors thrive.”
The article continues to highlight how the protein – called PKM2 – is very active during infancy in order to promote rapid cell growth, however gets turned off ultimately. HealthCanal.com reports that cancer cells turn this protein back on, which then promotes the growth of tumors.
The research within the article also indicates that there is a vital spot along this protein’s pathway that can be attacked with a type of drug that has not yet been used against glioblastoma multiform, which is the most lethal type of brain cancer.
In response to the findings, VABC representative Clay Darrohn states that “VABC is very excited about these new findings, and we hope that this drug will work against PKM2 to help reduce the risk of brain tumors. We also hope that this will lead to cancer awareness and further funding for brain cancer research.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC’s mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.